Status: Not yet recruiting
Study of Supplemental Arginine With Chemotherapy and Immunotherapy in Platinum Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer
This is an open-label, Phase 1 clinical study to evaluate the safety, tolerability, PK profiles, and clinical activity of IV and PO arginine supplementation + SOC chemoimmunotherapy regimens in participants with PROC.
Participants needed: 24
Trial details
Phase: Phase 1Age: 18-89Biological sex: FemaleType: InterventionalSponsor: Rebecca ArendUpdated: Aug 19, 2026Locations: 1
Eligibility criteria
Must be at least 18 years of age [+14]
History of allergic reactions contributed to compounds of similar chemical or bi... [+8]